rs188096

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000452.3(SLC10A2):​c.511T>G​(p.Ser171Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.873 in 1,603,298 control chromosomes in the GnomAD database, including 612,123 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S171D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.88 ( 59227 hom., cov: 31)
Exomes 𝑓: 0.87 ( 552896 hom. )

Consequence

SLC10A2
NM_000452.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.26

Publications

53 publications found
Variant links:
Genes affected
SLC10A2 (HGNC:10906): (solute carrier family 10 member 2) This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010]
SLC10A2 Gene-Disease associations (from GenCC):
  • bile acid malabsorption, primary, 1
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.8493375E-6).
BP6
Variant 13-103052694-A-C is Benign according to our data. Variant chr13-103052694-A-C is described in ClinVar as Benign. ClinVar VariationId is 403446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.923 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC10A2NM_000452.3 linkc.511T>G p.Ser171Ala missense_variant Exon 3 of 6 ENST00000245312.5 NP_000443.2 Q12908

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC10A2ENST00000245312.5 linkc.511T>G p.Ser171Ala missense_variant Exon 3 of 6 1 NM_000452.3 ENSP00000245312.3 Q12908

Frequencies

GnomAD3 genomes
AF:
0.881
AC:
133943
AN:
152016
Hom.:
59176
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.930
Gnomad AMI
AF:
0.975
Gnomad AMR
AF:
0.812
Gnomad ASJ
AF:
0.867
Gnomad EAS
AF:
0.737
Gnomad SAS
AF:
0.842
Gnomad FIN
AF:
0.880
Gnomad MID
AF:
0.838
Gnomad NFE
AF:
0.881
Gnomad OTH
AF:
0.869
GnomAD2 exomes
AF:
0.854
AC:
214594
AN:
251138
AF XY:
0.858
show subpopulations
Gnomad AFR exome
AF:
0.930
Gnomad AMR exome
AF:
0.762
Gnomad ASJ exome
AF:
0.871
Gnomad EAS exome
AF:
0.736
Gnomad FIN exome
AF:
0.883
Gnomad NFE exome
AF:
0.883
Gnomad OTH exome
AF:
0.864
GnomAD4 exome
AF:
0.872
AC:
1264980
AN:
1451164
Hom.:
552896
Cov.:
33
AF XY:
0.871
AC XY:
629678
AN XY:
722656
show subpopulations
African (AFR)
AF:
0.932
AC:
30996
AN:
33242
American (AMR)
AF:
0.765
AC:
34205
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.870
AC:
22686
AN:
26062
East Asian (EAS)
AF:
0.723
AC:
28659
AN:
39626
South Asian (SAS)
AF:
0.855
AC:
73586
AN:
86052
European-Finnish (FIN)
AF:
0.885
AC:
47287
AN:
53406
Middle Eastern (MID)
AF:
0.869
AC:
4995
AN:
5748
European-Non Finnish (NFE)
AF:
0.880
AC:
970536
AN:
1102336
Other (OTH)
AF:
0.867
AC:
52030
AN:
60000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
7312
14624
21936
29248
36560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21042
42084
63126
84168
105210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.881
AC:
134047
AN:
152134
Hom.:
59227
Cov.:
31
AF XY:
0.878
AC XY:
65294
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.930
AC:
38604
AN:
41494
American (AMR)
AF:
0.811
AC:
12394
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.867
AC:
3007
AN:
3470
East Asian (EAS)
AF:
0.737
AC:
3805
AN:
5166
South Asian (SAS)
AF:
0.842
AC:
4050
AN:
4812
European-Finnish (FIN)
AF:
0.880
AC:
9321
AN:
10592
Middle Eastern (MID)
AF:
0.839
AC:
245
AN:
292
European-Non Finnish (NFE)
AF:
0.881
AC:
59894
AN:
68010
Other (OTH)
AF:
0.871
AC:
1838
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
810
1621
2431
3242
4052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.878
Hom.:
279388
Bravo
AF:
0.877
TwinsUK
AF:
0.883
AC:
3275
ALSPAC
AF:
0.874
AC:
3368
ESP6500AA
AF:
0.931
AC:
4102
ESP6500EA
AF:
0.873
AC:
7505
ExAC
AF:
0.861
AC:
104496
Asia WGS
AF:
0.805
AC:
2801
AN:
3478
EpiCase
AF:
0.878
EpiControl
AF:
0.881

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.0
DANN
Benign
0.33
DEOGEN2
Benign
0.035
T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.028
T
MetaRNN
Benign
0.0000028
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.74
N
PhyloP100
1.3
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.47
N
REVEL
Benign
0.16
Sift
Benign
1.0
T
Sift4G
Benign
0.72
T
Polyphen
0.0
B
Vest4
0.066
MPC
0.0053
ClinPred
0.00049
T
GERP RS
5.8
Varity_R
0.068
gMVP
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs188096; hg19: chr13-103705044; COSMIC: COSV55360754; API